Ashley Graves
Psychiatric/Mental Health · Spindale, NCNPI 1902324338
Payments from drug & device makers
Across 299 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$651
- AbbVie$592
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$558
- Otsuka America Pharmaceutical, Inc.$522
- Vanda Pharmaceuticals Inc.$505
- Alkermes, Inc.$342
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,146100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $651 |
| AbbVie | 48 | $592 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $558 |
| Otsuka America Pharmaceutical, Inc. | 36 | $522 |
| Vanda Pharmaceuticals Inc. | 25 | $505 |
| Alkermes, Inc. | 21 | $342 |
| Teva Pharmaceuticals USA, Inc. | 13 | $217 |
| Sunovion Pharmaceuticals Inc. | 15 | $217 |
| Neos Therapeutics, LP | 14 | $201 |
| Neurocrine Biosciences, Inc. | 10 | $200 |
| Lundbeck LLC | 8 | $168 |
| Supernus Pharmaceuticals, Inc. | 7 | $146 |
| Jazz Pharmaceuticals Inc. | 8 | $125 |
| Bausch Health US, LLC | 8 | $121 |
| Almatica Pharma LLC | 5 | $116 |
| Corium, LLC | 5 | $114 |
| Axsome Therapeutics, Inc. | 4 | $106 |
| Johnson & Johnson | 4 | $100 |
| Eisai Inc. | 6 | $85 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $12 |
How this compares
$5,146 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 17 | $591 |
| Hydroxyzine Hcl | 18 | $242 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 29 | $222 |
| Escitalopram Oxalate | 22 | $210 |
| Buspirone Hcl | 26 | $200 |
| Trazodone Hcl | 45 | $179 |
| Duloxetine Hcl | 22 | $176 |
| Aripiprazole | 11 | $159 |
| Prazosin Hcl | 16 | $148 |
| Mirtazapine | 12 | $148 |
| Olanzapine | 12 | $119 |
| Lamotrigine | 19 | $98 |
| Bupropion XlBupropion Hcl | 11 | $79 |
| Propranolol Hcl | 20 | $38 |
| Sertraline Hcl | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $116 | $3711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Spindale
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.